https://www.marketscreener.com/quote/stock/OSE-IMMUNOTHERAPEUTICS-21120309/news/Phase-3-Clinical-Trial-of-Tedopi-OSE-Immunotherapeutics-Announces-Positive-Top-Line-Results-for-S-30290737/?utm_source=telegram&utm_medium=social&utm_campaign=share